Publications dans lesquelles il/elle collabore avec Marta Ruiz Ortega (21)

2024

  1. Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice

    International Journal of Molecular Sciences, Vol. 25, Núm. 17

  2. Inhibition of BRD4 Attenuates ER Stress-induced Renal Ischemic-Reperfusion Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 5, pp. 1547-1562

2023

  1. BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease

    Antioxidants, Vol. 12, Núm. 5

  2. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Ccn2 increases tgf‐β receptor type ii expression in vascular smooth muscle cells: Essential role of ccn2 in the tgf‐β pathway regulation

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  2. Demethylation of H3K9 and H3K27 Contributes to the Tubular Renal Damage Triggered by Endoplasmic Reticulum Stress

    Antioxidants, Vol. 11, Núm. 7

  3. Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis

    Pharmaceuticals, Vol. 15, Núm. 2

  4. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

    Frontiers in Pharmacology, Vol. 13

  5. The CCN2 Polymorphism rs12526196 Is a Risk Factor for Ascending Thoracic Aortic Aneurysm

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2019

  1. Bromodomain and extraterminal proteins as novel epigenetic targets for renal diseases

    Frontiers in Pharmacology, Vol. 10

  2. Signal Integration and Transcriptional Regulation of the Inflammatory Response Mediated by the GM-/M-CSF Signaling Axis in Human Monocytes

    Cell Reports, Vol. 29, Núm. 4, pp. 860-872.e5

2018

  1. Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology

    Mediators of Inflammation, Vol. 2018

2017

  1. BET Proteins: An Approach to Future Therapies in Transplantation

    American Journal of Transplantation, Vol. 17, Núm. 9, pp. 2254-2262

  2. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage

    Journal of the American Society of Nephrology, Vol. 28, Núm. 2, pp. 504-519

2016

  1. The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury

    Kidney International, Vol. 89, Núm. 2, pp. 399-410

2015

  1. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Human Immunology, Vol. 76, Núm. 2-3, pp. 75-78

2014

  1. Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

    Laboratory Investigation, Vol. 93, Núm. 7, pp. 812-824

2011

  1. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H

    Mitochondrion, Vol. 11, Núm. 1, pp. 176-181

  2. The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB

    Journal of the American Society of Nephrology, Vol. 22, Núm. 7, pp. 1315-1325